Objectives: The aim was to assess the effect of wool use in patients with fibromyalgia.
Introduction
T he syndrome of fibromyalgia consists of a constellation of complaints including chronic pain and tender points. 1 It is often accompanied by other symptoms including weakness, muscle-joint aches, nonrestorative sleep, fatigue, stiffness, tension headache, irritable bowel and bladder syndrome, cognitive dysfunction, dry eyes, paresthesias, and restless legs syndrome. [2] [3] [4] [5] [6] The existence of fibromyalgia in patients is established by using the American College of Rheumatology 1990 Fibromyalgia Classification Criteria. According to these criteria, people who have suffered from chronic widespread musculoskeletal pain lasting at least 3 months and who have more than 11 painful tender points with palpation are diagnosed as having fibromyalgia. 7 The incidence of fibromyalgia in Turkey is gradually increasing every year. Thus, research is needed to identify effective and efficient therapeutic interventions. 8 The etiology of fibromyalgia is unknown, its pathogenesis is not clearly understood, and no standard treatment regimen exists. Its treatment requires a multidisciplinary approach of both pharmacological and nonpharmacological interventions. The goal of treatment is to reduce pain, improve the quality of sleep, and to increase the physical activity of patients with the intention of improving the overall health of muscles required in the performance of daily functions. 2, 3, 5, 6, 9, 10 Patients with fibromyalgia typically have aggravated symptoms during periods of cold. 2, 3, 4, 11, 12, 13 Women are especially susceptible to severe pain during cool, rainy, or humid weather. 14, 15 On the other hand, warm and=or dry
Atatü rk University, School of Nursing, Erzurum, Turkey. weather reduces the symptoms of fibromyalgia. 16 Additionally, changes in weather conditions worsen the symptoms of the disease. 17 Clothes fulfill a basic human need to maintain body temperature (homeostasis) by protecting the body against temperature changes and other external effects. [18] [19] [20] The heat-keeping capacity of animal wool is higher than that of plant or synthetic fibers. In addition, wool fiber, particularly knitted wool, forms sites of isolation where air is stored, especially if the wool fiber is knitted from wool threads. [21] [22] [23] Wool textile is one of the most hygroscopic. It is able to absorb 30%-50% of its weight in dampness and, therefore, it is able to pull sweat away from the body, thus protecting it from temperature change. [21] [22] [23] It is the nurse, who is part of the health care team that delivers treatment to patients with fibromyalgia, who serves as a guide to these patients, providing them with information about the disease and additional professional support. One especially important function that the nurse provides is to encourage patients to make necessary lifestyle changes to ease their symptoms. 9, 24, 25 In this capacity she should warn patients with fibromyalgia to avoid exacerbating factors such as cold and damp weather 26 and to advise them to wear suitable clothes and to use bedding materials that will protect their bodies from temperature fluctuations and dampness.
Aim
The aim of this study was to assess the effect that woolen underwear and woolen bedding (including woolen bed liners, woolen quilt and pillow) would have on the symptoms of patients with fibromyalgia. The study used a Visual Analogue Scale (VAS), tender point count, and Fibromyalgia Impact Questionnaire (FIQ) to assess the improvement in symptoms of patients with fibromyalgia who used woolen clothing and bed covers relative to those who did not.
Design and Methods

Study design
The patients selected from this study were distributed into two blocks, Group I and Group II. Each block (group) consisted of 25 patients who were selected on the basis of gender (all female), work experience, education level, age, and marital status (Fig. 1) . The two groups were statistically identical (Table 1) . Within the constraints required to generate two statistically identical groups, the patients were randomly selected and assigned to their respective groups. Patients in Group I received the woolen garment and bedding, while those in Group II acted as the placebo group, receiving nonwool bedding and clothing.
Patient selection
The people who participated in this study were patients with fibromyalgia, who had applied to an outpatient clinic specializing in physical treatment and rehabilitation in Ankara, Turkey and who had volunteered for the study.
Study inclusion criteria
Patients, who were diagnosed based on American College of Rheumatology criteria and had no other conditions as determined by their clinical and laboratory evaluations, were used as samples in this study. All patients were screened by undergoing additional laboratory tests including a complete blood count, erythrocyte sedimentation rate, hepatic=renal function test, C-reactive protein level, glucose, thyroid stimulating hormone level, and x-ray film. All patients were 18 years of age or older and living in the municipality of Ankara. None of the patients had a history of using wool, nor had they received regular physical treatment for the 2 months prior to the start of the study. Furthermore, none of the patients used antidepressants regularly. Data were collected during the months of January through March, which are the winter months in Turkey.
Interventions
The VAS, F-IQ, and tender points count were applied in the hospital (pre-test). The day after each patient had completed the initial evaluation, the author visited the patient at her home to provide the treatment materials (woolen garments and bedding for the patients in Group I and non- 
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woolen garments and bedding for the patients in Group II) and to provide instructions on the appropriate use of those materials. In addition, patients were required to keep a daily record of the use of the treatment materials. During the home visits to the patients in the treatment group, the author provided wool underwear (which covered the body from the shoulders to the thighs), a wool bed liner, wool quilt, and pillow. In order to ensure that the patients immediately used the materials provided to them, the author made the bed for each patient by inserting the wool bed liner between the mattress and the cover sheet, by placing wool quilt on the bed, and by replacing the patient's pillow with one made of wool. The patients were instructed (and were expected) to use the wool material for the duration of the study which lasted 6 weeks. In addition patients, were asked to keep track of their daily use of medications using a simple checklist (Yes or No) to indicate their use or non-use of medicine, respectively. The patients in the treatment group were instructed by the author to wear their woolen underwear constantly, to sleep in the bed insulated with the 1-cmthick woolen bed liner, and to use the woolen pillow and quilt for 6 weeks. The composition of the woolen underwear was 75% merino wool and 25% acrylic fiber. The bedding materials (bed liner, woolen quilt, and pillow) were made from 100% sheep wool. It is worth noting that the patients in the treatment group had worn cotton underwear, and had used bedding materials made of synthetic materials before they participated in the study.
The author also visited patients in the control group, and provided them with cotton underwear and bedding materials (bed liner, quilt, and pillow) made of synthetic material. These materials were the placebo. As in the experimental group, the patients in the control group were instructed to use their materials for 6 weeks. Again, to ensure that the patients complied with the experimetal regimen, the author made the patients' beds for them using the bedding materials she had provided and made sure that the patients were wearing their long underwear. Identical checklists were provided to the patients in the control group as were given to the experiemtal group; patients were asked to keep track of their daily use of medication using a simple checklist (Yes or No) to indicate their use or nonuse of medicine, respectively. The patients in control group were not provided with any wool materials. The underwear used in this study was made from 100% cotton. Bedding materials were composed of 100% synthetic fiber. The placebo materials (garments and bedding) were similar to those that were used by the treatment group in terms of shape and dimensions; only the colors differed. Moreover, it is important to note that the sleeping materials used by the patients in the control group were the same type that they were accustomed to using.
The author controlled the use of wool by patients in the treatment group and the use of placebo materials in the control group by visiting each patient on a weekly basis for 6 weeks to ensure that the patients were adhering to the experimental regimen. The author checked to make sure that the patients were wearing the undergarments (woolen for patients in the treatment group or cotton for patients in the control group) with which they had been provided and that they were using the bedding materials (woolen bedding materials for patients in the treatment group or synthetic bedding materials for patients in the control group).
At the conclusion of the 6-week study period, the patients came to the hospital for an evaluation that consisted of the same tests that were applied at the beginning of the study period: the VAS, FIQ, and tender point count. These poststudy evaluations are designated by the phrase ''post-test.'' Throughout the trial, the patients in both groups did not take any medicine other than analgesics and=or nonsteroidal anti-inflammatory drugs (NSAIDs) nor did they receive, to the best of the author's knowledge, any physical treatment. Upon the completion of this study, the information and results supporting the benefits of wool use were given to the patients in the control group.
Assessments
Data were collected through the VAS, tender points count, and FIQ. All the patients were assessed both at the onset (pre-test) and the end of 6th week (post-test) of the study. In addition, the patients in both groups were provided with checklists with which they maintained a daily record of the analgesic and=or nonsteroidal anti-inflammatory drugs they used during the study. Clinical nurses, who were not a part of the study, applied both the pre-and post-tests of VAS and FIQ to the patients. The tender point count was determined through an examination given by a physical treatment and rehabilitation specialist blinded as to whether the patient was in the treatment or control group. Both the pre-and post-tests were carried out by the same physician who also was unaware of the treatment the patient had received.
A statistical analysis, based on a two-sided a of 0.05 with a power of 0.95 was applied to the data to compare the use of wool in the treatment group with its nonuse in the control group.
Measurements
The 10-cm VAS (VAS 0-10; 0 ¼ no pain, 10 ¼ worst pain) was used for the assessment of pain intensity.
The American Collage of Rheumatology tender point count was used to assess the existence of fibromyalgia. These criteria require that pain be present in 11 of 18 sites when pressure is applied to the tender point through palpation. At each tender point, the health care provider applies 4 kg of pressure by placing his=her thumb pad on the surface of the patient's skin until the nail tip of the thumb begins to blanch. If a patient verbally reports pain, grimaces, moans, or withdraws from the examiner, the test is considered positive for that tender point. 10 There are two tender points for each of the following locations on the human body, one on each side of the sagittal plane: the occiput, low cervical, trapezius, subraspinatus, second rib, lateral epicondyle, gluteal, greater trochanter, and knee. 5 As previously mentioned, the number of days patients used an analgesic and=or nonsteroidal anti-inflammatory drugs was tracked daily through a checklist with simple ''yes'' or ''no'' responses for the use or nonuse, respectively, of these medications.
The FIQ was used to evaluate the daily activity of patients and to assess the presence of the symptoms of fibromyalgia. The FIQ consists of 10 questions. The first question is an 11-part questionaire used to evaluate the level of physical activity of the patient during the week prior to the administration of the FIQ. Each part of the question is rated on a 4-point Likerttype scale. Items 2 and 3 inquire about the patient's overall sense of wellness, asking specifically how many days they felt well (Question 2) and how many days they were unable to work (including housework) in the preceding week (Question 3). Questions 4 through 10 probe the physical and mental symptoms of the disease, inquiring about the patient's level of work impairment, level of pain, fatigue, morning tiredness (awoke well rested ¼ 0, awoke very tired ¼ 10), stiffness, anxiety, and depression. The total FIQ score ranges between 0 and 100 determined by summing the subscores, ranging from 0 to 10, for each of the 10 questions. The FIQ and subscores are scored in such a way that a higher score indicates a greater impact of the syndrome on the person. 27 The Turkish version of the FIQ was validated by Sarmer et al. 8 
Statistical analysis
Statistical analyses were performed by using the SPSS (Statistical Package for Social Sciences for Windows) 11.5 PC program. Demographic and baseline clinical characteristics were described using the mean and standard deviation of the mean. All data except age (in years) and and duration of the disease (years) were reported as a percentage of the categorical variable (Table 1) . In order to compare the treatment group with the control group with respect to pre-test data and 
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post-test data, the independent samples t-test was used (Table 2) . To make a comparison of pre-and post-test results within the treatment group alone, however, the paired samples t-test was used (Table 3) .
Ethical Considerations
Before the study was undertaken, the consent of each patient was obtained and permission was granted by the Hacettepe University, Surgery and Medicine Application Ethic Board, Ankara, Turkey.
Results
The baseline characteristics of all 50 patients (Table 1) show that there were no significant (statistical) demographic and clinical differences between the treatment and control groups. The mean age was 37 years and the mean duration of the disease was 5þ years. Most patients were married (84%) and unemployed (60%) with low education levels. Analgesics and=or NSAID drugs were prescribed for all patients in the treatment and control groups (Table 1) .
There were no significant pre-test differences in pain level and tender point count. Also, the pre-test FIQ total score, and all 10 category subscores had no significant differences between the two groups ( p > 0.05; Table 2 ).
Making the same type of comparison as indicated in the previous paragraph, it was found that post-test scores for the treatment group were significantly better than those of the control group using the pain level measure and tender point count. Similarly, the total FIQ score and all 10 FIQ category scores of the treatment group were significantly lower than those of the control group ( p < 0.001; Table 2 ).
It was found out that the number of days the patients in control group used analgesics and=or NSAID drugs was higher than that of the treatment group ( p < 0.001; Table 2 ).
Patients in the treatment group experienced significant reduction in the symptoms of fibromyalgia determined by the pain level, tender point count, and FIQ. The total score of FIQ was reduced from *78 to *18, and all 10 categories of the FIQ were significantly reduced ( p < 0.001 all cases; Table 3 ).
Discussion
This study showed that the patients who used wool had a remarkable relief from pain intensity and a reduction in tender point counts. Woolen underwear used by the patients covered all tender points (trapezius, supraspinatus, gluteal, greater trochanter, low cervical, second rib, and lateral epicondyle) except for those on the occiput and knee. Jeschonneck et al 28 found that the temperature of the skin on a tender point was lower in the patients with fibromyalgia than that of healthy individuals and that blood flow was lower in patients with fibromyalgia ( p < 0.001). The authors attributed the pain in the tender points to the reduction of blood flow to the affected area. When the patients used wool in this study, we speculate that the reason for the lower pain level and reduction in the tender point count was the warmth of wool, which led to an increase in local blood flow, which in turn reduced the pain as a result of improved blood circulation.
Patients with fibromyalgia usually report fatigue and nonrestorative sleep. They experience an abnormality in the deepest stage of sleep, d-wave sleep.
1 Generally, in contrast to patients with fibromyalgia, most sleepers in the non-rapid eye movement stages 3 and 4 of sleep experience a drop in body temperature and relaxation of the muscles. 29 We found in this study that patients who used wool experienced a significant improvement in the quality of their sleep and that they reported feeling more refreshed and rested. In fact, in the treatment group, all patients woke up comfortably after the first day of the study. Patients with fibromyalgia, who are sensitive to the cold, maintained a constant and balanced body temperature because of wool clothing and bedding and, as a consequence, experienced more restorative sleep. The reduction in stiffness reflected better muscle health. This was supported by the reduced scores in question 1 of the FIQ and the reduction of the number of work days missed.
Women with fibromyalgia experience difficulties in managing practical tasks because of weaker muscle strength and decreased endurance. Commonly mentioned tasks with which women reported having difficulties included those that required repetitive movements, those that required static muscle control such as holding tools or other objects, and standing or sitting in the same position for long periods of time. 30 The patients who used wool were able to carry heavy loads, were better able to stay in the same position for a longer period, and performed repetitive movements and physical activitives more easily than patients in the control group who had not used wool clothing and bedding.
The reduction in physical impairment, the increase in the number of days the patients reported feeling good, the reduction in the number of days of work missed, the reduction in the number of days the patients reported experiencing work impairment, and a concomitant reduction in anxiety and depression levels of the patients in the treatment group may be attributed to an overall reduction in pain and fatigue and an overall improvement in the quality of their sleep. The people using wool clothing and bedding also reported using analgesics and=or NSAIDs less frequently than their counterparts in the control group (Table 2 ). These results suggest that a reduction in the pain and other symptoms had occurred in the group receiving wool treatment.
Study Limitations
The study should be considered as a pilot study to determine the effect of wool use in patients with fibromyalgia. A lack of similar studies makes it difficult to discuss the results in terms of previous research. The short experimental period of one and a half months implies that an experiment carried out over a longer period, perhaps covering all seasons, may be more complete and revealing. No male patients were used in this study because fibromyalgia is more prevalent among females than males. However, it would be worthwhile to undertake a similar study of males suffering from fibromyalgia. Grants for these types should be made available in the future.
Conclusions
Patients with fibromyalgia who wore wool underwear and used wool-based bedding experienced significant improvements in their symptoms as measured by the pain score, tender point count, and all scores on the FIQ. The use of wool in the patients with fibromyalgia should be recommended as an inexpensive and easy way to mitigate and reduce the symptoms of the disease. Furthermore, it is suggested that this exploratory study be extended to assess the overall effectiveness of wool in patients with fibromyalgia and to further assess its use as a nonpharmacological method of treatment.
